Through their multiple targets, microRNAs (miRNAs) are involved in numerous physiological and pathological processes. In this study, miR-342-3p was found to be deregulated with ossification of ligament or osteoporosis. We demonstrate that silencing miR-342-3p impairs osteoblast activity and matrix mineralization, while over expression of miR-342-3p promotes osteoblast differentiation significantly. Moreover, miR-342-3p directly targets activating transcription factor 3 (ATF3), which inhibits transcription of pro-osteogenic differentiation-associated genes. In addition, there exists a higher frequency of methylation at the CpG island of the Enah/Vasp-Like (EVL) locus in undifferentiated pre-osteoblasts; however, demethylation of the EVL CpG island induces over expression of miR-342-3p during osteogenic differentiation. This study suggests that miR-342-3p may serves as a potential marker for diagnosis and treatment of ossification of ligament and osteoporosis.
homeostasis in adults [1] . Osteoclasts, originating from the myelomonocytic lineage, are multinucleated giant cells and can degrade existing bone through an acidic and enzymatic process [2] . Imbalance between the activity and number of osteoblasts and osteoclasts during bone remodeling will lead to reduced or increased bone mass, such as osteoporosis or ossification [3] . Ossification of ligamentum flavum (OLF), caused by a variety of reasons such as local mechanical factors, metabolic abnormalities and family genetics, is an ectopic ossification in the flavum ligament located in the connection site between adjacent vertebral arches, resulting in oppression of the nerve root and spinal cord [4, 5] . Morphological studies demonstrate that ossification of ligamentum, for instance, OPLL, is developed from a regulated endochondral ossification process initiated from the mesenchymal stem cells (MSCs) differentiating into chondrocytes [6, 7] . Osteoblast lineage commitment, proliferation and differentiation are controlled by a well-defined genetic program [8] [9] [10] . Therefore, it is very important to lucubrate the regulatory mechanism of bone remodeling.
MicroRNAs (miRNAs), found in a variety of organisms, are single-stranded noncoding RNAs with 22 nucleotides. They inhibit the cognate target genes expression via binding and cleaving messenger RNAs (mRNAs) specifically, inhibiting translation, or deadenylating mRNA tails [11] . With multiple and diverse targets, miRNAs are involved in numerous biological function and pathological processes including cell proliferation [12] , differentiation [13, 14] , and apoptosis [15] . Latest studies indicated the process of osteoblast differentiation was governed by distinct miRNAs. For instance, miR-206 inhibits osteoblasts differentiation by binding connexin 43 (Cx43) which is a major gap junction protein in osteoblasts, while regaining the expression of Cx43 in miR-206-expressed osteoblasts rescues the repressive effect of miR-206 on osteogenic differentiation [16] . Special inhibition of miR-188 in bone mesenchymal stem cells (BMSC) promotes bone formation and reduces bone marrow fat accumulation in elderly mice [17] . Other studies pointed out miR-2861 promote primary mouse osteoblasts differentiation by repressing the expression of histone deacetylase 5 (HDAC5), which is an enhancer of runt-related transcription factor 2 (RUNX2) degradation [18] . Furthermore, accumulated evidence suggest that disease cells release abundant RNAs into the blood, which are resistant to RNases in the bloodstream and exist in sufficient levels to be analyzed quantitatively [19] . Circulating biomarkers are useful screening tools because of the ease and relatively noninvasive nature of their collection [20] [21] [22] . However, there is a lack of functional miRNAs as the connection among ossification, osteogenic differentiation and osteoporosis. Therefore, it is urgent to identify circulating miRNAs which are directly related to the osteogenic differentiation and could be used as diagnostic markers of ossification and osteoporosis.
In this study, we identified an over-expressed miRNA, miR-342-3p, from the OLF using an miRNA sequencing analysis. Our results illustrated that miR-342-3p was up-regulated significantly during the process of bone formation, and down-regulated observably in the process of bone loss. When miR-342-3p was knocked down in human mesenchymal stem cells (hMSCs) and mouse pre-osteoblast cells, the expression of the pro-osteogenic differentiation associated genes including alkaline phosphatase (ALP), osteocalcin (OCN), collagen type I alpha 1 (Col1a1) and RUNX2 were down-regulated. However, over expression of miR-342-3p promoted osteoblast differentiation significantly. Moreover, activating transcription factor 3 (ATF3) was identified as a direct target of miR-342-3p which eliminates ATF3-mediated inhibition of osteogenic differentiation. In addition, a higher frequency of methylation exists at the Enah/Vasp-Like (EVL) locus in undifferentiated cells, and demethylation of EVL CpG island induces over expression of miR-342-3p in the process of osteogenic differentiation. Taken together, our work demonstrated that miR-342-3p promotes osteogenic differentiation by eliminating the inhibitory effect of ATF3, suggesting that miR-342-3p may not only be a biomarker to monitor ossification and osteoporosis in human but also have potential as a candidate for novel treatment strategies.
Materials and methods

Study population
The ossified LF and normal LF tissues were obtained from OLF or spinal trauma patients who underwent posterior decompression laminectomy. The serums were collected from patients diagnosed as OLF or osteoporosis, or matched blood donor volunteers recruited from Tianjin Medical University General Hospital. Clinical samples were obtained after receiving informed consent from the patients. The study methodologies conform to the standards set by the Declaration of Helsinki. The study has been approved by the Ethical Committee of the Tianjin Medical University General Hospital.
Cell cultures and treatment
The primary hMSCs (Cyagen Biosciences lnc., Guangzhou, China) and the mouse pre-osteoblast cells MC3T3-E1 clone 4, were cultured in alpha modified eagle's medium (aMEM, Invitrogen, Camarillo, CA, USA) supplemented with 1% penicillin and streptomycin (Gibco, Camarillo, CA, USA) and 10% fetal bovine serum (FBS, Gibco). The hFOB1.19 cells and HT-29 cells were maintained in dulbecco's modified eagle medium/F12 (DMEM/F12, Invitrogen) with 1% penicillin and streptomycin and 10% FBS [23] . The HEK293T cells were cultured in DMEM (Invitrogen) containing 1% penicillin and streptomycin and 10% FBS. All cells were cultured under conditions of 5% CO 2 . Confluent cells were digested with 0.25% trypsin including 10 mM EDTA, re-suspended in corresponding medium and plated into plates with a suitable density. To induce osteoblast mineralization, 50 lgÁmL À1 of ascorbic acid (Sigma-Aldrich, Merck KGaA, Darmstadt, Germany), 5 mM glycerol 2-phosphate (SigmaAldrich, Merck KGaA) and 10 nM dexamethasone (SigmaAldrich, Merck KGaA) were added to culture medium.
Osteoporotic mouse model
The animal experimental protocols were approved by Tianjin Medical University Animal Care and Use committee. The methods were carried out in accordance with the approved guidelines. All C57BL/6J female and male mice were provided by the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences (Beijing, China). The mice were raised with free access to water and food at 22-25°C. The female mice were randomized and divided into two groups (n = 10 per group). Ovariectomized (OVX) mice had their ovaries removed, and sham-operated mice had their ovaries exposed but not removed at the age of 12 weeks. At 6 months after surgery, all the OVX and sham-operated mice were euthanized to dissect bilateral femurs. For hindlimb unloading or sham, the mice were randomized and divided into two groups (n = 10 per group, each group included five male and five female mice, respectively) at the age of 12 weeks. The hindlimb unloading mice were suspended with 30°angle to the floor and only the forelimbs to touch the floor allowing them to move and access water and food. At 4 weeks after tail suspension (TS), the mice were euthanized to collect bilateral femurs. By rapidly peeling off the muscles and other cartilage tissue attached to the femur, and rushing out the bone marrow with syringe, the clean femoral tissues were frozen for further RNA extraction.
Microcomputed tomography analysis
The left femurs dissected from the mice were fixed in 10% formalin for 24 h, then scanned and analyszed with Inveon PET.SPECT.CT, Inveon Acquisition Workplace, COBRA_Exxim:Licensed to Siemens and Ineon Research Workplace. X-ray current and voltage were set to 500 lA and 80 kV with the resolution of 8.5 lm per pixel. The region of interest (ROI) selected for analysis was distal femur beginning 0.1 mm below the growth plate and extending 100 layers proximally along the femur diaphysis. All trabecular bones were segmented for three-dimensional reconstruction (threshold=1000) to calculate the parameters, including bone surface area/bone volume (BS/BV), bone volume/total volume (BV/TV), trabecular spacing (Tb. Sp), trabecular thickness (Tb. Th), and trabecular number (Tb. N).
Alkaline phosphatase staining
Alkaline phosphatase staining was monitored using a 5-Bromo-4-Chloro-3-Indolyl Phosphate/Nitroblue tetrazolium chloride (BCIP/NBT) Alkaline Phosphatase Color Development Kit (C3206, Beyotime Institute of Biotechnology, Shanghai, China) in accordance with the instructions. Briefly, cells were fixed by immersion in 4% paraformaldehyde at 4°C for 30 min, and rinsed in phosphate buffer saline (PBS) for 5 min. The alkaline phosphatase stain was then added into the plates for 30 min, preventing the plates from light. The pictures were monitored by microscopy after rinsing in deionized water for 5 min.
Assay for Alkaline phosphatase activity
The alkaline phosphatase activity was detected using an Alkaline Phosphatase Assay Kit (P0321, Beyotime Institute of Biotechnology, Shanghai, China) in accordance with the instructions. Briefly, cells were firstly lysed using RIPA lysis buffer (Beyotime Institute of Biotechnology), and after centrifugation for 18 800 g, 30 min, the supernatant was removed into a 96-well plate. Para-nitrophenyl phosphate was subsequently added and incubated at 37°C for 10 min. The ALP activity was finally monitored at the wavelength of 405 nm.
Alizarin red staining and quantity
Cells were fixed in 70% ice-cold ethanol and placed at 4°C for 1 h and then rinsed using deionized water. Cells were then stained with 40 mM Alizarin red S (Sigma-Aldrich, Merck KGaA), pH4.0, with gentle shaking for 5 min. Finally, cells were rinsed with deionized water for three times, and the pictures were monitored by microscopy. Quantitation analysis was performed for five random fields in each preparation with image J, and average percentages of positive area were plotted.
Extraction of DNA and RNA
Genomic DNA from the cultured cells was extracted using Universal Genomic DNA Kit (CW2298M, CWBIO). Total RNA from tissues and cells was extracted with Trizol reagents (Takara, Dalian, China), and total RNA from serum samples was extracted with Trizol LS reagent (Invitrogen).
Quantitative polymerase chain reaction
Total RNA was reversely transcribed using the First-strand cDNA synthesize kit (B532451, Sangon) for miRNA, or First-strand cDNA synthesize kit (#K1622, Thermo Fisher Scientific, Waltham, MA, USA) for mRNA in accordance with the instructions. The synthesized cDNA templates were further amplified by SYBR Green master kit (Takara) under the conditions: 15 min at 95°C for denaturation, 40 cycles of 95°C for 30 s and 60°C for 30 s with the Light Cycler Ò 96 Real-Time PCR System (Roche, Mannheim, Germany) [24] . The expression level of GAPDH was used to normalize the expression levels of the mRNAs-of-interest, and the expression level of U6 was used to normalize the expression levels of the miRNAs. We calculated the relative expression values by comparing the normalized cycle threshold (Ct). The sequences of primers for quantitative polymerase chain reaction are listed in Table S1 .
Methylation specific PCR
The genomic DNA was modified with sodium bisulfite using the DNA Methylation Kit (CW2140M, CWBIO). The genes were amplified by Taq Master Mix (CW0690, CWBIO) with the specific primer which is contrary to methylated or unmethylated alleles in the CpG islands among the promoter region of the EVL gene. The PCR parameters: 94°C for 2 min, 40 cycles of segments of 94°C for 30 s, 60°C for 30 s, and 72°C for 30 s, at last, 72°C for 2 min (Eppendorf). After amplification, the PCR products were subjected to 1.5% agarose gel electrophoresis and subsequently visualized. The sequences of primers for MSP are listed in Table S1 .
ATF3 3
0 UTR cloning and luciferase assay
Activating transcription factor 3 mRNA 3 0 UTRs containing the miR-342-3p-binding sequences were amplified from human genomic DNA by PCR. Then the PCR products were cloned into the XbaI site of the pGL3 empty vector (Promega, Madison, WI, USA). Binding-region mutations were achieved using a Quik Change Lightning Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, CA, USA) following the instructions. All the construct sequences were verified by automated DNA sequencing. The cells were co-transfected with luciferase constructs containing 2 lgÁmL À1 wild-type (WT) or mutant (Mut) ATF3 3 0 UTR vectors and 200 lM agomir-342-3p or negative control. The renilla luciferase was used as an internal control for transfection efficiency. Luciferase activity was assayed with the dual-luciferase reporter system (Promega). The PCR primers are listed in Table S1 .
Immunoblot and immunoprecipitation
The procedures of western blot were previously reported [25] . In brief, cells were lysed with RIPA lysis buffer (Beyotime) including 1% phosphatase inhibitor and 1% phenylmethanesulfonyl fluoride (PMSF 
Chromatin immunoprecipitation
Cells were cultured in 15 cm dishes to 90% confluent. The 1% formaldehyde was added into the medium for 10 min at room temperature (RT) to cross-link the chromatin. The fixation was terminated by treatment with 0.125 M glycine at RT for 5 min. The cells were washed with PBS three times for 5 min and gathered in 670 lL SDS Buffer including protease inhibitors (PMSF). Lysate was centrifuged at 100 g, and followed by resuspension with 460 lL IP Buffer involved in 1 volume SDS Buffer and 0.5 volume Triton Dilution Buffer. The chromatin was sonicated with 5s on/15s off for 30 cycles at 30% power and then centrifuged at 20 000 g for 30 min. The supernatant was removed to a new tube and protein concentration was quantitated by the BCA Protein Assay Kit according to the instruction. Next, the samples were diluted to a suitable concentration with IP Buffer and 10 lL (1%) lysate was taken out as input. Every IP sample was performed in 1 mL buffer. Lysates were incubated with antibodies (5 lg IgG or 5 lg ATF3) at 4°C rotating overnight. A total of 40 lL beads were added into the mixture and further incubated 4 h at 4°C. Next, the beads were removed, the immunoprecipitated mixtures were washed three times with wash buffer containing 1 mL 150 mM wash buffer and 500 mM wash buffer, respectively, and followed 120 lL buffer containing 1% SDS, 0.1 M NaHCO 3 were added and incubated at 65°C overnight. Finally, DNA was purified with PCR purification kit (Qiagen, Dusseldorf, Germany) and used as templates for PCR reactions. Primers used in chromatin immunoprecipitation (ChIP)-qPCR are described in Table S1 .
Lentivirus production and construction
The oligo encoding ATF3 shRNA was inserted into pSU-PER.retro.puro plasmid, and the fragment including the H1 promoter and shRNA was inserted into the lentiviral shuttle pCCL.PPT.hPGK.GFP.Wpre. The full-length cDNA of ATF3 was amplified by PCR and inserted into the lentiviral shuttle pCCL.PPT.hPGK.IRES.eGFP/pre to construct the over-expressed plasmid. Together with the , and C57BL/6J mice of TS and age-matched control (E) (n = 10 per group). (F,G) qPCR analysis of miR-342-3p, ALP and OCN were performed with total RNA isolated from hMSCs (F) and MC3T3-E1 cells (G), treated with osteogenic medium for 0 day, 3 days and 6 days. U6 was used as an internal control for miRNA, GAPDH was used as an internal control for mRNA. Data are presented as means AE SEM for at least triplicate experiments. Statistical analysis was performed using Student's t test. *P < 0.05, **P < 0.01.
packaging plasmids pMD2.BSBG, pMDLg/pRRE and pRSV-REV, the plasmid containing shRNA or ATF3 cDNA was constructed to lentivirus in HEK-293T cells. The lentivirus was obtained at 48 h and 72 h after transfection and filtered by 0.45 lm filters. The primer sets used are shown in Table S1 .
Transfection assay
Human mesenchymal stem cells and MC3T3-E1 cells were cultured overnight until 50% confluence and then transfected with 200 lM antagomir-342-3p or 200 lM agomir-342-3p (supplied by GenePharma, Suzhou, China) using Lipofectamine 2000 (Invitrogen) according to the instructions. After 4-6 h of transfection, the medium containing transfection reagent was replaced by fresh medium. After culturing for an additional 48 h, cells were performed to further experiments.
Statistical analysis
Data were shown as mean AE SEM. The SPSS 20.0 (IBM, Armonk, NY, USA) was used to perform the statistical analysis. Student's t-test or one-way analysis of variance was performed to statistical analysis, followed by post hoc comparison. Differences with P < 0.05 were considered statistically significant.
Results
miR-342-3p is up-regulated in osteogenic differentiation
Systemic variations between the expressions of miRNAs in four human OLF samples and four normal ligamentum flavum (LF) samples were previously identified using miRNA sequencing analysis [26] , from which we noted that miR-342-3p was over-expressed in OLF (Fig. 1A) . (The sequence data have been uploaded to NCBI Gene Expression Omnibus and can be adopted by GEO Series accession number GSE106256). We then assessed the level of miR-342-3p in different tissues, serums, and cells to further definite its expression in osteogenic differentiation. First, qPCR analysis showed that the level of miR-342-3p, and the mRNA levels of the bone formation marker genes ALP and OCN, were over-expressed in ossified LF compared with normal LF (Fig. 1B) , confirming the results of miRNA sequencing analysis. In addition, we detected the expression of miR-342-3p in human serum and found that miR-342-3p was significantly increased in patients suffered from OLF compared with the healthy ones. Consistently, miR-342-3p level was decreased in the serum of patients with osteoporosis ( Fig. 1C) . Furthermore, we constructed OVX and TS mouse models (Fig. S1 ) and used the femurs from both models to evaluate miR-342-3p expression in osteoporosis. As shown in Fig. 1D ,E, the level of miR-342-3p and the mRNA levels of ALP and OCN were significantly reduced in both models. Finally, miR-342-3p expression was examined during the process of osteogenic differentiation and the results showed that miR-342-3p was over-expressed in hMSCs and MC3T3-E1 cells differentiating to osteoblasts (Fig. 1F,G) . Taken together, these data demonstrate that miR-342-3p was over-expressed in osteogenic differentiation and downexpressed in osteoporosis.
miR-342-3p promotes osteoblast activity and matrix mineralization
Reduction in the activity of osteoblast differentiation is a crucial feature of osteoporosis and is characterized by reduced deposition of ALP and formation of calcium nodules, together with down-regulated expression Fig. 2 . miR-342-3p promotes the osteogenic differentiation in hMSCs. (A) qPCR analysis of miR-342-3p with total RNA isolated from hMSCs after treatment with antagomir-342-3p, agomir-342-3p, negative controls or mock for 48 h. U6 was used as an internal control. (B) hMSCs were transfected with antagomir-342-3p or the negative control. Forty eight hours after transfection the cells were further cultured in osteogenic medium for 0, 3 and 6 days before total RNA and protein were extracted. The mRNA levels of ALP, OCN, Col1a1, and RUNX2 were detected by qPCR. GAPDH was used as an internal control. (C) The protein levels of ALP, OCN, Col1a1 and RUNX2 were detected by western blot after cells were induced for 6 days, and quantified with QUANTITY ONE software. GAPDH was used as an internal control. (D) hMSCs were transfected with agomir-342-3p or the negative control. Forty eight hours after transfection the cells were further cultured in osteogenic medium for 0, 3 and 6 days before total RNA and protein were extracted. The mRNA levels of ALP, OCN, Col1a1 and RUNX2 were detected by qPCR. GAPDH was used as an internal control. (E) The protein levels of ALP, OCN, Col1a1 and RUNX2 were detected by western blot after cells were induced for 6 days, and quantified with QUANTITY ONE software. (F) The ALP activity was detected in hMSCs transfected with antagomir-342-3p or agomir-342-3p, together with the corresponding controls, and further cultured in osteogenic medium for 6 days. (G) Representative image of ALP staining was performed with the above cells. Scale bars = 400 lm. (H,I) Staining (H) and the quantitation (I) of calcium deposition by Alizarin red in hMSCs after transfection with antagomir-342-3p or agomir-342-3p, together with the corresponding controls, and further cultured in osteogenic medium for 21 days. Scale bars = 400 lm. All the staining data were confirmed by at least three repeated tests. All data are presented as means AE SEM for at least triplicate experiments. Statistical analysis was performed using Student's t test. */#P < 0.05, **P < 0.01. In B and D, *P < 0.05 vs NC + 0 d, #P < 0.05 vs the corresponding NC.
patterns of particular genes, for instance, the collagen [27] . To investigate whether miR-342-3p regulates osteogenic differentiation, hMSCs were firstly transfected with either antagomir-342-3p (a miR-342-3p inhibitor) or agomir-342-3p (a miR-342-3p agonist) to knock down or over-express miR-342-3p, and then subjected to osteogenic induction. As shown by the results of qPCR, miR-342-3p could be effectively knocked down by treatment of antagomir or overexpressed by agomir, respectively ( Fig. 2A) . The expressions of pro-osteogenic differentiation associated genes were examined and the results showed that, the mRNA levels of ALP, OCN, Col1a1, and RUNX2 were down-regulated by knock-down of miR-342-3p and up-regulated by over expression of miR-342-3p over the differentiation time course, compared with controls, respectively (Fig. 2B,D) . The protein levels of these genes were decreased after knock-down of miR-342-3p and increased after over expression of miR-342-3p in osteogenic induction (Fig. 2C,E) . Consistent with the data of qPCR and immunoblot, antagomir-342-3p weakened Alp activity and staining, whereas agomir-342-3p enhanced Alp activity and staining (Fig. 2F,G) . Furthermore, we found that the mineral deposition was reduced in antagomir-342-3p transfected cells, and increased in agomir-342-3p transfected cells compared with the corresponding control via Alizarin red staining (Fig. 2H,I ). The same results were obtained in mouse MC3T3-E1 cells (Fig. S2 ). Taken together, these results suggest that miR-342-3p promotes the expression of pro-osteogenetic differentiation associated genes, the deposition of ALP and the formation of calcium nodules.
miR-342-3p directly represses the expression of ATF3
To further clarify the mechanism by which miR-342-3p promotes osteogenetic differentiation, miRWalk, and Miranda databases were used to predict the potential targets of miR-342-3p. Among the candidate target genes, ATF3 was identified with a putative miR-342-3p seed match site (Fig. 3A) . Systemic variations between the expression of mRNAs in four human ossified LF samples and four normal LF samples were previously identified using a microarray analysis [26] , from which we noted that ATF3 was remarkably down-regulated in ossified LF (Fig. 3B ) (The microarray data have been uploaded to NCBI Gene Expression Omnibus and can be adopted by GEO Series accession number GSE106253). To confirm the bioinformatics-based predictions, hMSCs were transfected with antagomir-342-3p or agomir-342-3p, and ATF3 mRNA and protein levels were measured by qPCR and immunoblot, respectively. Significant elevations of ATF3 transcript and protein were found in antagomir-342-3p transfected hMSCs compared with control (Fig. 3C,D) . However, transfection with agomir-342-3p showed a decline in ATF3 mRNA and protein levels compared with control ( Fig. 3E,F) . These results indicate that miR-342-3p regulates ATF3 expression.
To further determine whether miR-342-3p directly targets the ATF3 mRNA, we constructed luciferase reporters that harbor either a wild-type (WT) ATF3 3 0 UTR or an ATF3 3 0 UTR containing mutated sequences of the miR-342-3p binding site (Mut) (Fig. 3G) . We found that agomir-342-3p significantly repressed the luciferase activity of WT ATF3 3 0 UTR. However, the luciferase activity with Mut ATF3 3 0 UTR was not inhibited by agomir-342-3p (Fig. 3H) , suggesting that miR-342-3p represses the expression of ATF3 by directly binding to the 3 0 UTR of ATF3 mRNA.
ATF3 inhibits osteoblast activity and matrix mineralization
Activating transcription factor 3 has been shown to negatively regulate osteoblast differentiation via repressing the expression of ALP gene specifically in MC3T3-E1 cells [28] . To further testify that miR-342-3p-mediated ATF3 down-regulation was responsible for osteogenic differentiation, we knocked down ATF3 with shRNA or over-expressed ATF3 with lentivirus in the process of osteogenic differentiation of hMSCs. We found that the expression of ATF3 was substantially down-regulated by treatment of shRNA (Fig. 4A,B) and markedly up-regulated by treatment of lentivirus (Fig. 4C,E) . The expressions of pro-osteogenic differentiation associated genes including ALP, OCN, Col1a1, and RUNX2 were upregulated when ATF3 was knocked down (Fig. 4A,B) , while down-regulated when ATF3 was over-expressed ( Fig. 4D,E) . Furthermore, knockdown of ATF3 also enhanced Alp activity and staining, whereas over expression of ATF3 reduced its activity and staining (Fig. 4F,  G) . In addition, Alizarin red staining demonstrated more mineral deposition in ATF3-shRNA-treated cells and less mineral deposition in lentivirus-ATF3-treated cells (Fig. 4H,I ). Taken together, these results indicate that ATF3 inhibits the expression of pro-osteogenic differentiation associated genes, and the subsequent deposition of alkaline phosphatase and the formation of calcium nodules.
ATF3 mediates the effect of miR-342-3p
To investigate whether miR-342-3p promotes the expression of pro-osteogenic differentiation associated genes through ATF3, we firstly transfected the cells with antagomir-342-3p and found that ATF3 resumes its repressive effect on the expressions of the marker genes when miR-342-3p was knocked down. However, the expressions of those genes were no longer changed when both miR-342-3p and ATF3 were knocked down, indicating that ATF3 mediates the effect of miR-342-3p (Fig. 5A,B) . It has been reported that ATF3 reduces the activity of a luciferase reporter harboring the ALP promoter [28] , indicating putative ATF3 binding site(s) at the promoter. Therefore, we predicted potential ATF3 binding sites in ALP, OCN, Col1a1 and RUNX2 promoter regions using JASPAR and subsequently performed ChIP analysis in hMSCs to explore the underlying molecular mechanism by which miR-342-3p targets ATF3 to regulate the expression of the pro-osteogenic differentiation associated genes. The results showed that ATF3 binds to the promoters of ALP, OCN, Col1a1, and RUNX2, and the binding was further enhanced when miR-342-3p was knocked down (Fig. 5C,D) . These data indicate that miR-342-3p exerts the pro-osteogenic effect by releasing ATF3 from the promoter of the target genes.
DNA methylation at the EVL/miR-342 locus is infrequent in osteogenic differentiated cells
It has been reported that the transcription of EVL and its intron transcription product miR-342 are commonly WT or Mut) and agomir-342-3p or negative control. Luciferase activity was measured 72 h post transfection. All data are presented as means AE SEM for at least triplicate experiments. Statistical analysis was performed using Student's t test. *P < 0.05. NS, not significant. Fig. 4 . Activating transcription factor 3 inhibits the osteogenic differentiation in hMSCs. (A-E) hMSCs were infected with lentivirus-mediated shATF3 (A,B) or lenti-ATF3 (C-E), and cultured in osteogenic medium for 6 days. The mRNA and protein levels of ATF3, ALP, OCN, Col1a1 and RUNX2 were detected by qPCR and western blot. GAPDH was used as an internal control. (F) The ALP activity was detected in hMSCs infected with lentivirus-mediated shATF3 or lenti-ATF3 together with the corresponding controls, and cultured in osteogenic medium for 6 days. (G) Representative image of ALP staining was performed with the above cells. Scale bars = 400 lm. (H,I) Staining (H) and the quantitation (I) of calcium deposition by Alizarin red in hMSCs after transfected with lentivirus-mediated shATF3 or lenti-ATF3 together with the corresponding control, and cultured in osteogenic medium for 21 days. Scale bars = 400 lm. All the staining data were confirmed by at least three repeated tests. All data are presented as means AE SEM for at least triplicate experiments. Statistical analysis was performed using Student's t test. *P < 0.05, **P < 0.01.
suppressed in human colorectal cancer, and the mechanism of silencing is CpG island methylation upstream of EVL [29] . Given the evidence that miR-342-3p is upregulated in osteoblast differentiation (Fig. 1F,G) , we investigated whether the expression of its host gene EVL is also up-regulated in osteogenic differentiated hMSCs and human pre-osteoblast hFOB1.19 cells. As shown in Fig. 6A and C, EVL transcription was found to be upregulated after osteoblast differentiation relative to the undifferentiated cells, suggesting a positive correlation between up-regulation of EVL and miR-342-3p in osteoblast differentiation. These results support a model that the expression of EVL and miR-342-3p is coordinately regulated in osteogenic differentiation. To determine the mechanism responsible for EVL/miR-342-3p up-regulation in differentiated osteoblast, we evaluated the methylation of the CpG island of the EVL gene in hMSCs and hFOB1.19 cells using methylation-specific PCR (MSP).
The results showed that there was a higher DNA methylation at the EVL/miR-342-3p locus in undifferentiated cells and a reduced methylation in differentiated cells (Fig. 6B,D) . These results suggest that it is the demethylation of EVL that induces the over expression of miR-342-3p in osteogenic differentiated cells.
Discussion
The growth and maintenance of skeleton depend on osteoblasts which are bone-forming cells of the remodeling unit. This research identified miR-342-3p as a vital regulator of bone formation under physiological and pathophysiological status. Our data indicate that over expression of miR-342-3p in osteoblasts may facilitate skeleton formation and even reverses osteoporosis through an anabolic effect. A variety of miRNAs have been widely investigated in various Enrichment was shown relative to input. All data are presented as means AE SEM for at least triplicate experiments. Statistical analysis was performed using either Student's t test (two-group comparison) or one-way analysis of variance (more than two groups). *P < 0.05. NS, not significant.
biological processes including homeostasis of osteogenesis, and multiple miRNAs have been found to regulate the expression of osteogenic differentiation associated genes at the post-transcriptional level [16] [17] [18] 30] . However, no miRNA correlated with both ossification and osteoporosis has yet been identified. In this study, we found increased miR-342-3p levels in both ossified ligament and plasma of the patients with OLF, and decreased levels in plasma of patients with osteoporosis and the femurs of both OVX and TS mice. This finding offers the clinical foresight into the dedication of miR-342-3p to the regulation of bone formation. MiR-342-3p has previously been reported to be over expressed in the brains of bovine spongiform encephalopathy (BSE)-infected macaques, and downexpressed in extranodal natural killer (NK)/T-cell lymphoma (ENKTCL) and osteosarcoma tissues and cell lines, indicating that miR-342-3p implicates in regulating proliferation, apoptosis, migration and invasion [31] [32] [33] . A recent study indicates that miR-342-3p promotes osteogenic differentiation of umbilical cord MSCs via inhibiting Sufu in vitro [34] . In this study, we defined a novel mechanism whereby miR-342-3p regulates the expression of ATF3 in hMSCs by binding the ATF3 3 0 UTR. Our study further investigated the role of miR-342-3p during the process of osteogenesis. It has been reported that ATF3 inhibits or activates target genes transcription, depending on diverse factors, for instances, binding sequences, complex partners, or cell types [35, 36] . The amount of ATF3 protein is strictly controlled through transcriptional, translational and post-translational mechanisms in different cellular contexts [37] . Our experimental evidence strongly demonstrates that ATF3 can be a direct target of miR-342-3p and mediates the regulatory role of miR-342-3p on osteogenic differentiation. It is known that ATF3 specifically binds the promoter of ALP and regulates its expression and activation which has critical roles in bone and hard tissue formation and is detectable in the early stage of osteoblast differentiation [28] . Although high level of ALP leads to the mineralization of neotissue, other genes are involved in bone formation as well. Our data reveal that ATF3 acts directly on the promoter regions of the pro-osteogenic differentiation associated genes including ALP, OCN, Col1a1, and RUNX2 to exert an inhibitory effect of the transcription. Thus, miR-342-3p promotes osteogenic differentiation by releasing the inhibitory effect of ATF3 on pro-osteogenic differentiation associated genes.
MiR-342-3p, localized to 14q32, is an intronic miRNA, and the promoter region of its host gene EVL is embedded in a CpG island [29] . EVL is a protein of the Ena/VASP family, the actin-related proteins, which are implicated in various processes associated with cell polarity and cytoskeleton remodeling such as axon guidance and lamellipodial and filopodial dynamics in migrating cells [38] . It is possible that EVL could function as a pro-osteogenic differentiation factor through effects on cell shape or motility. Our data indicate that miR-342-3p and EVL were coordinately up-regulated, under the infrequently DNA methylation at the EVL/has-miR-342 locus. According to the above observations, we put forward that the methylated DNA of the CpG island within EVL/miR-342-3p locus may deserve further research as a biomarker for noninvasive disease detection or risk prediction for OLF or osteoporosis, especially considering its obvious specificity for osteoblast differentiation. Given that roughly half of miRNA genes are located in introns, we propose that this kind of coordinate regulation may on behalf of a more universal mechanism of miRNA different expression.
In summary, our study identified miR-342-3p as a novel regulator that positively regulates osteogenic differentiation by directly binding to ATF3 and subsequently abolishes ATF3-mediated repression on the transcription of pro-osteogenic differentiation associated genes (Fig. 7) , suggesting that miR-342-3p can be a candidate marker and a target in OLF or osteoporosis.
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